Literature DB >> 17912678

Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.

Maurício Cavicchioli1, Clarice Q F Leite, Daisy N Sato, Antonio C Massabni.   

Abstract

The present work describes the synthesis and antimycobacterial activity of three Ag(I)-complexes with the sweeteners aspartame, saccharin, and cyclamate as ligands, with the aim of finding new candidate substances for fighting tuberculosis and other mycobacterial infections. The minimal inhibitory concentration of these three complexes was investigated in order to determine their in-vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium malmoense, and Mycobacterium kansasii. The MIC values were determined using the Microplate Alamar Blue Assay. The best MIC values found for the complexes were 9.75 microM for Ag(I)-aspartame against M. kansasii and 15.7 microM for Ag(I)-cyclamate against M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912678     DOI: 10.1002/ardp.200700040

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  Synthesis, Characterization, and Antimicrobial Investigation of a Novel Chlorhexidine Cyclamate Complex.

Authors:  Viktor Dubovoy; Primit Desai; Zhigang Hao; Chi-Yuan Cheng; Gaurav Verma; Lukasz Wojtas; Tatiana V Brinzari; Jeffrey M Boyd; Shengqian Ma; Tewodros Asefa; Long Pan
Journal:  Cryst Growth Des       Date:  2020-05-04       Impact factor: 4.076

2.  Di- and polynuclear silver(I) saccharinate complexes of tertiary diphosphane ligands: synthesis, structures, in vitro DNA binding, and antibacterial and anticancer properties.

Authors:  Veysel T Yilmaz; Elif Gocmen; Ceyda Icsel; Murat Cengiz; Sunde Y Susluer; Orhan Buyukgungor
Journal:  J Biol Inorg Chem       Date:  2013-10-17       Impact factor: 3.358

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.